RPTX - Repare Therapeutics GAAP EPS of -$0.70 beats by $0.02 revenue of $6.88M beats by $3.6M March, 01 2022 04:54 PM Repare Therapeutics Inc. Repare Therapeutics press release (NASDAQ:RPTX): Q4 GAAP EPS of -$0.70 beats by $0.02. Revenue of $6.88M (+4814.3% Y/Y) beats by $3.6M. For further details see: Repare Therapeutics GAAP EPS of -$0.70 beats by $0.02, revenue of $6.88M beats by $3.6M